NR3C2 and Alzheimer disease: In addition to neuronal functions, we showed in this study that melanocortin/MCR replenishment alleviates the activation of microglia and astrocytes, thereby restoring cellular homeostasis, rendering MCRs and their agonists attractive targets for AD therapeutic development.